Study reveals Pfizer bivalent COVID-19 booster safer for seniors against stroke risk compared to other vaccines

The comparative hazard of ischemic stroke (IS) in recipients of booster shots.

First-Line Immunotherapy Alone Sufficient for Older NSCLC Patients, Study Suggests

Adding an immune checkpoint inhibitor (ICI) to chemotherapy for older patients with previously untreated advanced non-small cell lung cancer (NSCLC) provided no survival advantage compared

March 8, 2024

Pharmalittle: FDA flags safety concerns with CRISPR-based sickle cell treatment; FDA warns about eye drop infection risk

Good morning, everyone, and welcome to another working week. We hope the weekend respite was refreshing and invigorating, because that oh-so familiar routine of online

October 30, 2023

For national security, the U.S. must maintain its biotech dominance

For more than a century, the United States has been the undisputed leader in medical and biotechnology innovation. It saved millions of lives by mass-producing

April 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.